Secreted Phosphoprotein 1 Promoter Genetic Variants Are Associated with the Response to Pegylated Interferon α Plus Ribavirin Combination Therapy in Egyptian Patients with Chronic Hepatitis C Virus Infection.

Gut Liver · 2015 · PMC4477996 · PMID 25717047

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In addition, the SVR rate was higher in patients with T/T genotype than in those with C/T genotype, but this difference did not reach statistical significance.

also in 111,027 other papers

highly significantno p-value reported

On the other hand, there were highly significant differences in the posttreatment levels of ALT, AST, ALP, GGT, total bilirubin, total protein, albumin, and HCV RNA levels between the patients of both SVR and non-SVR groups.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.